InChIKey	HIFJCPQKFCZDDL-ACWOEMLNSA-N
Compound Name	Iloprost
Canonical SMILES	CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	5
Pfam Stratification	Homologous
Avg pChEMBL	7.2
Source	BindingDB;ChEMBL

DrugBank ID	DB01088
Drug Name	Iloprost
CAS Number	78919-13-8
Groups	approved investigational
ATC Codes	B01AC11
Description	Iloprost is an analog of prostacyclin (PGI2; epoprostenol), an endogenous prostanoid mainly produced in the vascular endothelium. It is more stable than prostacyclin, which is short-lived.[A263326] Iloprost consists of a mixture of the 4R and 4S diastereoisomers at a ratio of approximately 53:47.[L5...

---

Categories: Agents Causing Muscle Toxicity Antiplatelet agents Autacoids Biological Factors Blood and Blood Forming Organs Cardiovascular Agents Eicosanoids Fatty Acids Fatty Acids, Unsaturated Hematologic Agents Hypotensive Agents Inflammation Mediators Lipids OATP2B1/SLCO2B1 substrates Platelet Aggregation Inhibitors Excl. Heparin Prostacyclin Analogues Prostaglandins Prostaglandins, Synthetic Vasodilating Agents

---

Cross-references: BindingDB: 23954 ChEBI: 63916 CHEMBL494 ChemSpider: 4470703 PharmGKB: PA164746843 PubChem:5311181 PubChem:46507818 RxCUI: 40138 Therapeutic Targets Database: DAP000273 Wikipedia: Iloprost